Scale-up– tag –
-
Sartorius Accelerates Cell & Gene Therapy Commercialization with Comprehensive End-to-End Solutions
Sartorius Germany Overview Sartorius emphasizes its mission to accelerate the commercialization of cell and gene therapies (CGT) by providing end-to-end solutions that deliver reproducible performance and scalability. Its portfolio suppo... -
Forge Biologics Advances AAV Manufacturing with Optimized FUEL Platform and Announces Strategic Expansion into Asia-Pacific Gene Therapy Market
Forge Biologics USA Overview Forge Biologics has announced advancements in its FUEL platform for adeno-associated virus (AAV) manufacturing. This optimization aims to enhance vector yield and consistency during process scale-up through r... -
Tetra Pak Unveils Bioreactor RF, Revolutionizing Precision Fermentation Scaling with Patented Magnetic Agitation System
Food and Drink Technology UK Overview Tetra Pak has launched its first dedicated industrial bioreactor, the 'Bioreactor RF,' specifically designed to address key scaling bottlenecks in precision fermentation. The bioreactor features a pa... -
Drug Discovery News Analyzes Viral Vector Manufacturing Scale-Up Challenges for Gene Therapies, Highlighting AAV Production Bottlenecks
Drug Discovery News USA Overview Drug Discovery News focuses on the significant scale-up challenges in viral vector manufacturing for gene therapies, particularly emphasizing bottlenecks in adeno-associated virus (AAV) production. The ar... -
KyooBe Tech Unveils Rapid Vaccine Development Method with Low-Energy Electron Beam Irradiation (LEEI): Potential for Distributed Production and CGT Applications
BioSpace USA Overview KyooBe Tech has advanced a new method for vaccine development utilizing low-energy electron beam irradiation (LEEI) for rapid pathogen inactivation. This technology can process up to 300 mL of liquid per hour, with ... -
Cell and Gene Therapy Manufacturing Advances: Continuous Processing and Automated Bioreactors Tackle Scalability and Cost Challenges
News-Medical.net UK Overview Cell and gene therapy (CGT) manufacturing faces significant challenges in scalability, efficiency, and cost reduction, but new advancements in continuous processing and closed, automated bioreactor technologi... -
6th iPSC Drug Development Summit to Address GMP Scale-Up Challenges, Focusing on Gene Editing Safety and QC Frameworks
BioInsights International Overview The 6th iPSC Drug Development Summit will primarily focus on challenges associated with scaling iPSC platforms to GMP standards. Key discussions will cover implementing GMP-compatible gene editing strat... -
NTHRYS Achieves 40% Cost Reduction in Dual Antigen CAR-T Manufacturing, Offers Off-the-Shelf NK Cell Expansion Services
NTHRYS International Overview NTHRYS has successfully reduced manufacturing costs for dual antigen CAR-T cell scale-up by 40% while accelerating time-to-clinic. Furthermore, the company now offers clinical-grade NK cell expansion and cry... -
Lonza’s OptiALTO™ Platform Achieves High Cell Density Culture, Significantly Reducing Biologics Manufacturing Costs
Lonza Switzerland Overview Lonza's OptiALTO™ platform enhances biologics manufacturing by enabling higher cell densities, which significantly reduces cost of goods by increasing productivity and efficient asset utilization. The platform ... -
GEA Expands Biotech Scale-Up with New $4.7M Sarstedt Technology Center for Precision Fermentation & Cell Cultivation
PPTI News Germany Overview GEA has opened a new US$4.7 million biotech Application and Technology Center in Sarstedt, Germany, dedicated to expanding capabilities in precision fermentation, cell cultivation, and industrial process scale-...
